Serum antioxidant capacity is preserved in peritoneal dialysis contrary to its robust depletion after hemodialysis and hemodiafiltration sessions

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 2, 2010, Pages 209-217

  Rysz, Jacek ^a   Stolarek, Robert A ^a   Pedzik, Adrianna ^a   Nowicki, Michał ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidant capacity; Dialysis; Oxidative stress; Reactive oxygen species

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTIOXIDANT; BILIRUBIN; REACTIVE OXYGEN METABOLITE; URATE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ADULT; AGED; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CASE-CONTROL STUDIES; FEMALE; FERRIC COMPOUNDS; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PICRATES; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS;

EID: 77950201741     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00785.x     Document Type: Article

References (28)

1. Pastian S, Bailey J. Dialysis therapy. New Engl J Med 1998 20 : 1428 1437.
2. Rysz J, Majewska E, Stolarek RA, Banach M, Cialkowska-Rysz A, Baj Z. The increased levels of soluble TNFα receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis. Am J Nephrol 2006 26 : 437 444.
3. Aslam S, Santha T, Leone A, Wilcox C. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int 2006 70 : 2109 2115.
4. Schettler V, Kühn W, Kleinoeder T et al. No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells. J Intern Med 2003 253 : 201 207.
5. Mellors A, Tappel AL. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J Biol Chem 1966 241 : 4353 4356.
6. Nishida J, Kawabata J. DPPH radical scavenging reaction of hydroxy- and methoxychalcones. Biosci Biotechnol Biochem 2006 70 : 193 202.
7. Abe N, Nemoto A, Tsuchiya Y, Hojo H, Hirota A. Studies on the 1,1-diphenyl-2-picrylhydrazyl radical scavenging mechanism for a 2-pyrone compound. Biosci Biotechnol Biochem 2000 64 : 306 313.
8. Chae S, Kim JS, Kang KA et al. Antioxidant activity of jionoside D from Clerodendron trichotomum. Biol Pharm Bull 2004 27 : 1504 1508.
9. Rabovsky A, Cuomo J, Eich N. Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects. Clin Chim Acta 2006 371 : 55 60.
10. Reyes MR, Sifuentes-Alvarez A, Lazalde B. Estrogens are potentially the only steroids with an antioxidant role in pregnancy: in vitro evidence. Acta Obstet Gynecol Scand 2006 85 : 1090 1093.
11. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power". The FRAP assay. Anal Biochem 1996 239 : 70 6.
12. Degraft-Johnson J, Kolodziejczyk K, Krol M, Nowak P, Krol B, Nowak D. Ferric-reducing ability power of selected plant polyphenols and their metabolites: implications for clinical studies on the antioxidant effects of fruits and vegetable consumption. Basic Clin Pharmacol Toxicol 2007 100 : 345 352.
13. Chen TS, Liou SY, Chang YL. Chemiluminescent analysis of plasma antioxidant capacity in uremic patients undergoing hemodialysis. Renal Failure 2008 30 : 843 847.
14. Kadkhodaee M, Hemmati M, Zahmatkesh M et al. Assessment of Plasma Antioxidant Status in Hemodialysis Patients. Ther Apher Dial 2008 12 : 147 151.
15. Rysz J, Stolarek RA, Pedzik A et al. Increased exhaled H2O2 and impaired lung function in patients undergoing bioincompatible hemodialysis. Int J Artif Organs 2007 30 : 879 888.
16. Kuppusamy UR, Indran M, Ahmad T, Wong SW, Tan SY, Mahmood AA. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Clin Chim Acta 2005 351 : 197 201.
17. Gerardi G, Usberti M, Martini G et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002 40 : 104 110.
18. Chen WT, Lin YF, Yu FC, Kao WY, Huang WH, Yan HC. Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels. Am J Kidney Dis 2003 42 : 158 166.
19. Antoniadi G, Eleftheriadis T, Liakopoulos V et al. Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial 2008 12 : 237 242.
20. Balogh N, Gaal T, Ribiczeyne PS, Petri A. Biochemical and antioxidant changes in plasma and erythrocytes of pentathlon horses before and after exercise. Vet Clin Pathol 2001 30 : 214 218.
21. Erdolan C, Unlüçerçi Y, Türkmen A, Kuru A, Cetin O, Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta 2002 322 : 157 161.
22. Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ. The relative contributions of vitamin E, urate, ascorbate, and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987 24 : 408 419.
23. MacLean PD, Drake EC, Ross L, Barclay C. Bilirubin as an antioxidant in micelles and lipid bilayers: its contribution to the total antioxidant capacity of human blood plasma. Free Radical Biol Med 2007 43 : 600 609.
24. Inagi R, Miyata T, Ueda Y et al. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid. Kidney Int 2002 62 : 679 687.
25. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002 35 : 269 273.
26. Lucchi L, Bergamini S, Iannone A et al. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs 2005 29 : 67 72.
27. Mandal AK, Woodi M, Sood V et al. Quantitation and characterization of glutathionyl haemoglobin as an oxidative stress marker in chronic renal failure by mass spectrometry. Clin Biochem 2007 40 : 986 994.
28. González RM, Puchades MJ, García Ramón R, Saez G, Tormos MC, Miguel A. Effect of oxidative stress in patients with chronic renal failure. Nefrologia 2006 26 : 218 225.